查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679432

焦虑和忧郁症治疗市场规模、份额、趋势分析报告：按药物类型、适应症、分销管道、地区和细分市场预测，2025 年至 2030 年

Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Drug Type, By Indication (Depression, Anxiety), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

焦虑和忧郁症治疗市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球焦虑和忧郁症治疗市场规模预计到2030年将达到192.8亿美元，预计2025年至2030年期间的复合年增长率为3.8%。

全球忧郁症盛行率的上升预计将在未来几年推动市场成长。近年来，由于设备和心理疗法的普及，对抗抗忧郁症的需求有所下降。

易患忧郁症的老年人数量不断增加，以及恐惧症和整体焦虑症等焦虑症的增加，进一步导致了预测期内对抗抗忧郁症治疗精神疾病的需求不断增长。此外，用于大脑刺激的医疗植入和使用基于智慧型手机应用程式的虚拟实境暴露疗法等先进治疗方法的引入为患者提供了创新的治疗选择。

焦虑和忧郁症治疗市场报告重点

  • 抗忧郁症领域占据市场主导地位，2024 年的收益占有率最高，为 32.4%。
  • 焦虑症在 2024 年占据市场主导地位，收益占有率为 55.4%。这是由于成熟经济体和发展中经济体中恐惧症、社交焦虑症和其他类似疾病的增加。
  • 由于患者更喜欢附近且值得信赖的药局，零售药局领域将在 2024 年占据最大的市场占有率，达到 55.4%。
  • 北美焦虑和忧郁症治疗市场占据全球市场主导地位，2024 年的收益占有率为 37.6%。

目录

第一章调查方法与范围

第二章执行摘要

第三章焦虑和忧郁症治疗市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析

第四章焦虑与忧郁症治疗市场：按药物类型进行的商业分析

  • 2024 年和 2030 年各药物类型的市场占有率
  • 药品类型细分仪表板
  • 2018 年至 2030 年药品市场规模、预测及趋势分析
  • 抗忧郁症
  • 抗焦虑药物
  • 抗惊厥药
  • 去甲肾上腺素促效剂
  • 非典型抗精神病药物

5. 焦虑症与忧郁症治疗市场：适应症业务分析

  • 2024年及2030年的指示市场占有率
  • 指示细分仪表板
  • 2018 年至 2030 年市场规模、预测与趋势分析（按适应症）
  • 忧郁症
  • 焦虑症

6. 焦虑与忧郁症治疗市场：通路业务分析

  • 2024年及2030年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018 年至 2030 年分销通路市场规模、预测与趋势分析
  • 医院药房
  • 零售药局
  • 其他的

第七章焦虑和忧郁症治疗市场：按地区估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Pfizer Inc.
    • H. Lundbeck A/S
    • GSK plc
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Johnson & Johnson Services, Inc.
    • AbbVie Inc.
    • Sanofi
Product Code: GVR-1-68038-731-5

Anxiety Disorders And Depression Treatment Market Growth & Trends:

The global anxiety disorders and depression treatment market size is estimated to reach USD 19.28 billion by 2030, registering to grow at a CAGR of 3.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

Anxiety Disorders And Depression Treatment Market Report Highlights:

  • The antidepressants segment dominated the market and accounted for the highest revenue share of 32.4% in 2024.
  • Anxiety led the market with a revenue share of 55.4% in 2024, fueled by the increased presence of phobias, social anxiety disorders, and other similar conditions in both established and growing economies.
  • The retail pharmacies segment held the largest market share of 55.4% in 2024 due to patients' preference for nearby, trustworthy pharmacies.
  • North America anxiety disorders and depression treatment market dominated the global market with a revenue share of 37.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Indication
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Anxiety Disorders and Depression Treatment Market: Drug Type Business Analysis

  • 4.1. Drug Type Market Share, 2024 & 2030
  • 4.2. Drug Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 4.4. Antidepressants
    • 4.4.1. Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.5. Anxiolytics
    • 4.5.1. Anxiolytics Market, 2018 - 2030 (USD Million)
  • 4.6. Anticonvulsants
    • 4.6.1. Anticonvulsants Market, 2018 - 2030 (USD Million)
  • 4.7. Noradrenergic Agents
    • 4.7.1. Noradrenergic Agents Market, 2018 - 2030 (USD Million)
  • 4.8. Atypical Antipsychotics
    • 4.8.1. Atypical Antipsychotics Market, 2018 - 2030 (USD Million)

Chapter 5. Anxiety Disorders and Depression Treatment Market: Indication Business Analysis

  • 5.1. Indication Market Share, 2024 & 2030
  • 5.2. Indication Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Depression
    • 5.4.1. Depression Market, 2018 - 2030 (USD Million)
  • 5.5. Anxiety
    • 5.5.1. Anxiety Market, 2018 - 2030 (USD Million)

Chapter 6. Anxiety Disorders and Depression Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Anxiety Disorders and Depression Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Anxiety Disorders and Depression Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Pfizer Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. H. Lundbeck A/S
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. GSK plc
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Merck & Co., Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Eli Lilly and Company
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AstraZeneca
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bristol-Myers Squibb Company
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Johnson & Johnson Services, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. AbbVie Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sanofi
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global anxiety disorders and depression treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 5. Global anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 6. Global anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7. North America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 9. North America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 10. North America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11. U.S. anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 12. U.S. anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14. Canada anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 15. Canada anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 16. Canada anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17. Mexico anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 18. Mexico anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20. Europe anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 22. Europe anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 23. Europe anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24. UK anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 25. UK anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 26. UK Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27. Germany anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 28. Germany anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 29. Germany anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30. France anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 31. France anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 32. France Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33. Italy anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 34. Italy anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 35. Italy anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36. Spain anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 37. Spain anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 38. Spain anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39. Norway anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 40. Norway anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 41. Norway Anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42. Denmark anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 43. Denmark anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 44. Denmark anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45. Sweden anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 46. Sweden anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 47. Sweden anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52. Japan anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 53. Japan anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 54. Japan anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55. China anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 56. China anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 57. China anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58. India anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 59. India anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 60. India anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61. Australia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 62. Australia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 63. Australia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64. South Korea anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 65. South Korea anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 66. South Korea anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67. Thailand anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 68. Thailand anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 69. Thailand anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70. Latin America anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 72. Latin America anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 73. Latin America anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74. Brazil anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 75. Brazil anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 76. Brazil anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77. Argentina anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 78. Argentina anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 79. Argentina anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Anxiety disorders and depression treatment market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84. South Africa anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 85. South Africa anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 86. South Africa anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90. UAE anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 91. UAE anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 92. UAE anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93. Kuwait anxiety disorders and depression treatment market, by drug type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait anxiety disorders and depression treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 95. Kuwait anxiety disorders and depression treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Anxiety disorders and depression treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug type and indication outlook (USD Million)
  • Fig. 10 Distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Anxiety disorders and depression treatment market dynamics
  • Fig. 13 Anxiety disorders and depression treatment market: Porter's five forces analysis
  • Fig. 14 Anxiety disorders and depression treatment market: PESTLE analysis
  • Fig. 15 Anxiety disorders and depression treatment market: Drug type segment dashboard
  • Fig. 16 Anxiety disorders and depression treatment market: Drug type market share analysis, 2024 & 2030
  • Fig. 17 Antidepressants market, 2018 - 2030 (USD Million)
  • Fig. 18 Anxiolytics market, 2018 - 2030 (USD Million)
  • Fig. 19 Anticonvulsants market, 2018 - 2030 (USD Million)
  • Fig. 20 Noradrenergic agents market, 2018 - 2030 (USD Million)
  • Fig. 21 Atypical antipsychotics market, 2018 - 2030 (USD Million)
  • Fig. 22 Anxiety disorders and depression treatment market: Indication segment dashboard
  • Fig. 23 Anxiety disorders and depression treatment market: Indication market share analysis, 2024 & 2030
  • Fig. 24 Depression market, 2018 - 2030 (USD Million)
  • Fig. 25 Anxiety market, 2018 - 2030 (USD Million)
  • Fig. 26 Anxiety disorders and depression treatment market: Distribution channel segment dashboard
  • Fig. 27 Anxiety disorders and depression treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 28 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 29 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Anxiety disorders and depression treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait anxiety disorders and depression treatment market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework